中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2008年
2期
127-130
,共4页
动脉硬化%高脂血症%黄精多糖
動脈硬化%高脂血癥%黃精多糖
동맥경화%고지혈증%황정다당
Arteriosclerosis%Hyperlipidemia%Polygona-polysaccharose
目的 探讨黄精多糖对高脂血症实验兔动脉粥样硬化斑块的消退作用.方法 将40只新西兰兔分为正常对照组(饲普通饲料)、模型组(饲胆固醇饲料)、辛伐他汀组(饲胆固醇饲料+辛伐他汀)、黄精多糖组(饲胆固醇饲料+黄精多糖),分笼喂养8周.分别于实验开始时、第2周末和第8周末,采用酶法检测血清总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、脂蛋白(a)[Lp(a)]水平.第8周末处死动物,光镜观察主动脉粥样硬化斑块消退情况.结果 实验前各组血脂检测指标差异无统计学意义.实验第2周末(治疗前),模型组、辛伐他汀组和黄精多糖组血清TC分别为(10.2 ±1.6)、(11.0 ±1.8)、(11.2±1.9)mmol/L,LDL-C分别为(9.85±1.65)、(9.80±1.54)、(10.08±1.88)mmol/L,Lp(a)分别为(656±106)、(700±151)、(666±111)mg/L均显著高于正常对照组[(1.3±0.3)mmol/L、(0.55±0.15)mmol/L、(106±15)mg/L,P<0.01].实验第8周末黄精多糖干预组TC、LDL-C、Lp(a)均显著低于治疗前[(6.0±2.0)mmol/L vs(11.2±1.9)mmol/L、(4.25±1.35)mmol/L vs(10.08±1.88)mmol/L、(55±14)mg/Lvs(666±111)mg/L,P<0.01],与模型组比较,黄精多糖组主动脉粥样硬化斑块基本消退.结论 一定剂量的黄精多糖(1.6 ml·kg-1·d-1)具有消退实验性高脂血症家兔主动脉粥样硬化斑块的作用.
目的 探討黃精多糖對高脂血癥實驗兔動脈粥樣硬化斑塊的消退作用.方法 將40隻新西蘭兔分為正常對照組(飼普通飼料)、模型組(飼膽固醇飼料)、辛伐他汀組(飼膽固醇飼料+辛伐他汀)、黃精多糖組(飼膽固醇飼料+黃精多糖),分籠餵養8週.分彆于實驗開始時、第2週末和第8週末,採用酶法檢測血清總膽固醇(TC)、高密度脂蛋白膽固醇(HDL-C)、低密度脂蛋白膽固醇(LDL-C)、脂蛋白(a)[Lp(a)]水平.第8週末處死動物,光鏡觀察主動脈粥樣硬化斑塊消退情況.結果 實驗前各組血脂檢測指標差異無統計學意義.實驗第2週末(治療前),模型組、辛伐他汀組和黃精多糖組血清TC分彆為(10.2 ±1.6)、(11.0 ±1.8)、(11.2±1.9)mmol/L,LDL-C分彆為(9.85±1.65)、(9.80±1.54)、(10.08±1.88)mmol/L,Lp(a)分彆為(656±106)、(700±151)、(666±111)mg/L均顯著高于正常對照組[(1.3±0.3)mmol/L、(0.55±0.15)mmol/L、(106±15)mg/L,P<0.01].實驗第8週末黃精多糖榦預組TC、LDL-C、Lp(a)均顯著低于治療前[(6.0±2.0)mmol/L vs(11.2±1.9)mmol/L、(4.25±1.35)mmol/L vs(10.08±1.88)mmol/L、(55±14)mg/Lvs(666±111)mg/L,P<0.01],與模型組比較,黃精多糖組主動脈粥樣硬化斑塊基本消退.結論 一定劑量的黃精多糖(1.6 ml·kg-1·d-1)具有消退實驗性高脂血癥傢兔主動脈粥樣硬化斑塊的作用.
목적 탐토황정다당대고지혈증실험토동맥죽양경화반괴적소퇴작용.방법 장40지신서란토분위정상대조조(사보통사료)、모형조(사담고순사료)、신벌타정조(사담고순사료+신벌타정)、황정다당조(사담고순사료+황정다당),분롱위양8주.분별우실험개시시、제2주말화제8주말,채용매법검측혈청총담고순(TC)、고밀도지단백담고순(HDL-C)、저밀도지단백담고순(LDL-C)、지단백(a)[Lp(a)]수평.제8주말처사동물,광경관찰주동맥죽양경화반괴소퇴정황.결과 실험전각조혈지검측지표차이무통계학의의.실험제2주말(치료전),모형조、신벌타정조화황정다당조혈청TC분별위(10.2 ±1.6)、(11.0 ±1.8)、(11.2±1.9)mmol/L,LDL-C분별위(9.85±1.65)、(9.80±1.54)、(10.08±1.88)mmol/L,Lp(a)분별위(656±106)、(700±151)、(666±111)mg/L균현저고우정상대조조[(1.3±0.3)mmol/L、(0.55±0.15)mmol/L、(106±15)mg/L,P<0.01].실험제8주말황정다당간예조TC、LDL-C、Lp(a)균현저저우치료전[(6.0±2.0)mmol/L vs(11.2±1.9)mmol/L、(4.25±1.35)mmol/L vs(10.08±1.88)mmol/L、(55±14)mg/Lvs(666±111)mg/L,P<0.01],여모형조비교,황정다당조주동맥죽양경화반괴기본소퇴.결론 일정제량적황정다당(1.6 ml·kg-1·d-1)구유소퇴실험성고지혈증가토주동맥죽양경화반괴적작용.
Objective To study the effect of polygona-polysaccharose on the elimination of atheromatous plaque.Methods Thirty adult New Zealand rabbits were fed with high-fat and cholesterol forage for 8 weeks to establish hyperlipidemia animal models and then randomly divided into 3 equal groups:model group,simvastatin group receiving simvastatin orally,and polygona-polysaccharose group receiving polygona-polysaccharose orally.Ten rabbits were fed with normal food as control forage.At weeks 0,2,and 8 the levels of total cholesterol(TC),high density lipoprotein cholesterol(HDL-C),low density lipoprotein cholesterol(LDL-C),and lipoprotein(a)[Lp(a)]were determined with enzyme method.At the end of the week 8,all rabbits were killed to observe the elimination of aorta atheromatous plaque by microscope.Results Before the experiment,there were no significant differences in the levels of serum lipids among all groups.At the end of week 2(before treatment),the levels of serum TC of the model group,simvastatin group,and polygona-polysaccharose group were(10.2 ±1.6)mmol/L,(11 ±1.8)mmol/L,and(11.2 ±1.9)mmol/L respectively,the LDL-C levels of the 3 groups were(9.85±1.65)mmol/L,(9.80 ±1.54)mmol/L,and(10.08±1.88)mmol/L respectively,the Lp(a)levels of the 3 groups were(656 ±106)mmol/L,(700 ±151)mmol/L,and(666±111)mmol/L respectively,all significantly higher than that of the control group[(1.3 ±0.3)mmol/L,(0.55 ±0.15)mmol/L,and(106 ±15)mg/L respectively,all P<0.01].At the end of week 8(after treatment),the levels of serum TC,LDL-C,and Lp(a)of the polygona-polysaccharose group were(6.0 ±2.0)mmol/L,(4.25 ±1.35)mmol/L,and(55 ±14)mg/Lrespectively,all significantly lower than that at the end of week 2 [(11.2±1.9)mmol/L,(10.08 ±1.88)mmol/L,and(666 ±111)mg/L respectively,all P<0.01].The aorta atheromatous plaques in the polygona-polysaccharose group were basically eliminated compared with that in the model group.Conclusion